Abiopharma

News list

Pappis Charles C 🟢 acquired 7.1K shares (2 derivative) of ACM Research, Inc. (ACMR) at $96.13 Transaction Date: Aug 12, 2026 | Filing ID: 034528

Full text

News bot Aug. 27, 2026, 1:30 a.m.
🔍 Pappis Charles C (Executive)

Company: ACM Research, Inc. (ACMR)

Report Date: 2026-08-12
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 7,128
Detailed Transactions and Holdings:
- Acquired 6,400 shares of Stock Option at $81.26 per share (Derivative)
  Date: 2026-08-12 | Code: A | Expires: 2036-08-11 | equity_swap_involved: 0 | shares_owned_after: 6,400.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 728 shares of Restricted Stock Units at $96.13 per share (Derivative)
  Date: 2026-08-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 728.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
Footnotes:
- F1: The option will vest and become exercisable immediately prior to the 2027 annual meeting of stockholders of the issuer, subject to continued service through the vesting date.
- F2: The price per restricted stock unit is based on the average closing market price of the Issuer's common stock for the 30 trading days preceding the grant day.
- F3: The restricted stock units should be vested immediately prior to the 2027 annual meeting of stockholders of the issuer, subject to continued service.